Compare SKY & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SKY | ALKS |
|---|---|---|
| Founded | 2010 | 1987 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Homebuilding | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 4.5B |
| IPO Year | 1994 | 2012 |
| Metric | SKY | ALKS |
|---|---|---|
| Price | $75.18 | $35.46 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 14 |
| Target Price | ★ $101.00 | $43.29 |
| AVG Volume (30 Days) | 503.2K | ★ 2.0M |
| Earning Date | 02-03-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 35.18 | N/A |
| EPS | ★ 3.12 | 1.43 |
| Revenue | ★ $2,483,448,000.00 | $1,475,899,000.00 |
| Revenue This Year | $7.79 | $24.26 |
| Revenue Next Year | $3.44 | $4.63 |
| P/E Ratio | $23.13 | ★ $21.11 |
| Revenue Growth | ★ 22.65 | N/A |
| 52 Week Low | $59.44 | $25.17 |
| 52 Week High | $99.17 | $36.32 |
| Indicator | SKY | ALKS |
|---|---|---|
| Relative Strength Index (RSI) | 39.46 | 74.10 |
| Support Level | $72.70 | $27.89 |
| Resistance Level | $79.16 | $35.65 |
| Average True Range (ATR) | 2.65 | 1.18 |
| MACD | -0.02 | 0.74 |
| Stochastic Oscillator | 38.20 | 91.05 |
Champion Homes Inc is a factory-built housing company in North America. The company is well positioned with an portfolio of manufactured and modular homes, ADUs, park-models and modular buildings for the single-family, multi-family, and other hospitality sectors. In addition to its core home building business, the company provides construction services to install and set-up factory-built homes, operates a factory-direct retail business with 72 retail locations across the United States, and operates Star Fleet Trucking, providing transportation services to the manufactured housing and other industries from several dispatch locations across the United States.
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.